Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezepelumab PK Study via APFS or AI vs Vial/Syringe in Healthy Adults
NCT03989544Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tezepelumab in asthma (3 arms), sponsored by AstraZeneca. Primary endpoints: Area Under the Time-Concentration Curve From Zero to Infinity at Day 113 and Maximum Observed Concentration at Day 113. Started Jun 2019; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03989544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03989544.